Synlogic
$3.339876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$3.33
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
$0.00 (0.00%) As of 6:03 PM UTC today
Why Robinhood?
You can buy or sell Synlogic and other stocks, options, and ETFs commission-free!
About SYBX
Synlogic, Inc. engages in the discovery and development of Synthetic Biotic medicines. It focuses in Phenylketonuria, Enteric Hyperoxaluria, Immuno Oncology solid tumors, inflammatory bowel disease, and vaccines and other inflammatory programs.
CEO
Aoife M. Brennan
Employees
72
Headquarters
Cambridge, Massachusetts
Founded
2017
Market Cap
139.18M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
774.83K
High Today
$3.40
Low Today
$3.27
Open Price
$3.38
Volume
171.55K
52 Week High
$5.11
52 Week Low
$1.74
Analyst Ratings
86%
of 7 ratings
Buy
86%
Hold
14%
Sell
0%
SYBX Earnings
-$0.48
-$0.32
-$0.16
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 7, Pre-Market